Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and agingLinda S. Steelman, James A. McCubrey, Franca Stivala et al.|Aging|2011Cited by 707
Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapyLinda S. Steelman, James A. McCubrey, Richard A. Franklin et al.|Leukemia|2011Cited by 263
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathwayAlberto M. Martelli, James A. McCubrey, Camilla Evangelisti et al.|Leukemia|2011Cited by 206
Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathwaysJames A. McCubrey, Alberto M. Martelli, Linda S. Steelman et al.|Journal of Cellular Physiology|2011Cited by 171